APPIAN CORP
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
APPN$52.35+2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders' Equity (Deficit)
(in thousands, except share data)
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Treasury Stock · Total Stockholders' Equity (Deficit) | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balance December 31, 2022 | 72,817,887 | $7 | $561,390 | $(7,246) | $(408,451) | $— | $145,700 |
| Net loss | — | — | — | — | (111,441) | — | (111,441) |
| Issuance of common stock to directors | 19,687 | — | — | — | — | — | — |
| Vesting of restricted stock units | 430,582 | — | (9,748) | — | — | — | (9,748) |
| Exercise of stock options | 98,610 | — | 752 | — | — | — | 752 |
| Stock-based compensation expense | — | — | 43,387 | — | — | — | 43,387 |
| Other comprehensive loss | — | — | — | (16,309) | — | — | (16,309) |
| Balance December 31, 2023 | 73,366,766 | 7 | 595,781 | (23,555) | (519,892) | — | 52,341 |
| Net loss | — | — | — | — | (92,262) | — | (92,262) |
| Issuance of common stock to directors | 20,216 | — | (369) | — | — | 369 | — |
| Vesting of restricted stock units | 418,899 | — | (13,533) | — | — | 5,546 | (7,987) |
| Exercise of stock options | 1,543,436 | — | (29,643) | — | — | 44,104 | 14,461 |
| Repurchase of common stock | (1,320,531) | — | — | — | — | (50,019) | (50,019) |
| Stock-based compensation expense | — | — | 39,045 | — | — | — | 39,045 |
| Other comprehensive income | — | — | — | 11,781 | — | — | 11,781 |
| Balance December 31, 2024 | 74,028,786 | 7 | 591,281 | (11,774) | (612,154) | — | (32,640) |
| Net income | — | — | — | — | 1,233 | — | 1,233 |
| Issuance of common stock to directors | 22,829 | — | — | — | — | — | — |
| Vesting of restricted stock units | 434,940 | — | (10,441) | — | — | 3,045 | (7,396) |
| Exercise of stock options | 107,821 | — | 1,098 | — | — | 20 | 1,118 |
| Repurchase of common stock | (639,751) | — | — | — | — | (20,000) | (20,000) |
| Stock-based compensation expense | — | — | 35,380 | — | — | — | 35,380 |
| Other comprehensive loss | — | — | — | (24,688) | — | — | (24,688) |
| Balance December 31, 2025 | 73,954,625 | $7 | $617,318 | $(36,462) | $(610,921) | $(16,935) | $(46,993) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.